Carina Biotech Symposium Program

Wednesday, 18 May 2022
Hotel Grand Chancellor Adelaide + online

Join from a PC, Mac, iOS or Android:
Password: 720700


 9:30 am – 10 am: TEA & COFFEE

10:00 am – 10:15 am
Emily Whitehead video + Welcome from Tom Whitehead, co-founder of the Emily Whitehead Foundation


10:15 am – 10:30 am
Acknowledgement of Country + Introduction – Dr Deborah Rathjen, CEO, Carina Biotech


10:30 am – 11:00 am
Professor Simon Barry, VP, CAR-T Manufacturing Program, Carina Biotech
Design and in vitro validation of a CAR-T cell against LGR5


11:00 am – 11:20 am – MORNING TEA


11:20 am – 11:50 am
Professor Shaun McColl, VP, Chemokine Receptor Platform, Carina Biotech
Preclinical evaluation of a CAR-T cell directed against LGR5


11:50 am – 12:30 pm
Dr Jose Iglesias MD, Chief Medical Advisor, Carina Biotech
CAR-T clinical trials: promises and challenges


12:30 pm – 1:15 pm: LUNCH


1:15 pm – 1:55 pm
Associate Professor Misty Jenkins
Developing a discovery pipeline for engineering novel CAR T for brain cancer


1:55 pm – 2:35 pm
Professor Michael Brown
GD2-CAR-T cell therapy for aggressive primary brain cancers: preclinical data


2:35 pm – 2:55 pm: AFTERNOON TEA


2:55 pm – 3:35 pm
Professor Claudine Bonder
Tumour biology: Understanding the microenvironment for better patient outcomes


3:35 pm – 4:50 pm
10 years on, what is the future of CAR-T therapy?
Panel discussion and Q&A, chaired by Dr Deborah Rathjen
Panellists: A/Prof Misty Jenkins, Dr Jose Iglesias MD, Professor Simon Barry, Professor Claudine Bonder


4:50 pm
Closing remarks – Professor Shaun McColl